NCCN Guidelines® Insights - T-Cell Lymphomas, Version 1.2021 |
1.00 |
11/10/2020 - 12:00am to 11/10/2021 - 12:00am |
NCCN Guidelines® Insights - Uveal Melanoma, Version 1.2019 |
1.00 |
02/10/2020 - 12:00am to 02/10/2021 - 12:00am |
NCCN Pharmacy Updates: New Agents for Soft Tissue Sarcoma and Gastrointestinal Stromal Tumors |
1.00 |
12/15/2020 - 12:00am to 04/30/2021 - 12:00am |
NCCN Pharmacy Updates: Treatment Advances for Pediatric B-Cell Non-Hodgkin's Lymphomas |
1.00 |
06/08/2020 - 12:00am to 02/07/2021 - 12:00am |
NCCN Pharmacy Updates: Updates in the Treatment of Pancreatic Adenocarcinoma |
1.00 |
12/15/2020 - 12:00am to 05/23/2021 - 12:00am |
NCCN Pharmacy Updates: Updates on Targeted Therapy in the Treatment of Metastatic Colorectal Cancer |
1.00 |
12/15/2020 - 12:00am to 06/20/2021 - 12:00am |
New Approaches to Multiple Myeloma Therapy |
1.00 |
05/12/2020 - 12:00am to 05/12/2021 - 12:00am |
New NCCN Guidelines for Pediatric Cancers: Advancements in the Management of Pediatric Acute Lymphoblastic Leukemia |
1.00 |
11/09/2020 - 12:00am to 04/04/2021 - 12:00am |
New NCCN Guidelines for Pediatric Cancers: Management of Pediatric Aggressive Mature B-Cell Lymphoma |
1.00 |
11/09/2020 - 12:00am to 04/04/2021 - 12:00am |
New NCCN Guidelines for Pediatric Cancers: Multidisciplinary Management of Wilms Tumor (Nephroblastoma) |
1.00 |
12/01/2020 - 12:00am to 04/11/2021 - 12:00am |
New Therapeutic Developments in Urothelial Cancer: Clinical Trial Evidence and Expert Guidance |
1.75 |
07/02/2020 - 12:00am to 07/02/2021 - 12:00am |
Novel and Emerging Treatment Strategies for Acute Myeloid Leukemia |
0.75 |
05/15/2020 - 12:00am to 03/01/2021 - 12:00am |
Optimizing Outpatient Care in Hematopoietic Cell Transplant Patients |
0.75 |
10/30/2020 - 12:00am to 10/30/2021 - 12:00am |
Optimizing the Management of Endometrial Cancer |
0.50 |
07/01/2020 - 12:00am to 03/01/2021 - 12:00am |
Optimizing Treatment for Head and Neck Cancers |
1.50 |
07/09/2020 - 12:00am to 03/01/2021 - 12:00am |